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Abstract 
 Cataracts due to age affect the ability to perform daily visual activities, thereby 
reducing independence, which can leave a person feeling depressed. This project is 
designed to study the relationships between cataract surgery and depression and vision-
related quality of life in an elderly population. Two groups were studied: Participants 
undergoing cataract surgery and a wait-list control group. Levels of depression and vision-
related quality of life were assessed at baseline and at one-month post-surgery/baseline 
point.  Changes in depressive symptoms did not differ between the two groups; however, 
vision-related quality of life and visual acuity are significantly increased with cataract 
removal surgery.  Examining the effects of cataract surgery on depression and quality of 
life will help better understand the full risks and benefits of cataract surgery. 
 iii 
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The Aging Population 
 Today about 40 million people in the United States are ages 65 or older, but this 
number will more than double to 89 million by 2050 (Jacobsen et al., 2011).  The 
majority of this growth in the elderly population will occur between 2010 and 2030, 
when the “baby boom” generation enters what is considered as the older population 
(Vincent & Velkoff, 2010).  During these years, the elderly population will grow by an 
average of 2.8% annually (U.S. Census Bureau).  In some countries such as Germany, 
Italy, and France, the percentage of the population ages 65 and older could be around 
30% by 2040 (Jacobsen et al., 2011).  With the increase in this population there will be 
many economic, demographic, and healthcare consequences.  This cohort is likely to stay 
in the work force longer than prior generations, projected to make up 25% of the 
American work-force by 2019 (Lee & Mather, 2008).  Not only will they stay in the work 
force longer, but also have an increase in geriatric specific health concerns.  With an 
increase in geriatric specific health concerns, elderly people could become a larger 
portion of the patients in hospitals and clinics in America and around the world.  One 
specific concern related to the elderly population will be an increase in cataracts and 
surgeries to treat them. 
Eyesight and Cataracts 
 Eyesight is one of the most fundamental senses that we have.  We depend on it to 
do most of our daily activities.  As a person gets older, they may not only lose their 
mobility and independence but also lose their eyesight, limiting what they can and cannot 
do for entertainment and social life.  Vision-related quality of life (VRQOL) refers to the 
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effects of vision on everyday activities (e.g. cooking, seeing steps/curbs, driving).  
Decreased visual function has been found to be associated with diminished VRQOL and 
general living activities, particularly vision-dependent activities (Kundston et.al., 2005).  
 Cataracts are one of the main causes of a decrease in visual acuity in elderly 
patients and thereby a decrease in VRQOL (Dana et al., 1990).  A cataract is the clouding 
of a lens, which is generally clear and helps to focus light on the retina (Kalina, 1997). 
An aggregation of the proteins within the lens due to aging is one of the main causes of a 
cataract (Kalina, 1997).  As a consequence, the light is dispersed and the images are 
blurry because they cannot easily be transmitted through the lens onto the retina.  There 
are numerous symptoms of cataracts some of which include cloudy or blurry vision, 
difficulty with night vision, halos around lights, yellowing of colors, and double vision.  
Cataracts can be graded by the average color and opalescence, on a scale from grade 1 
(mild/early) to grade 4+ (severe/advanced, milky or brownish) (Murrill et.al., 1995).  
Furthermore, these grades indicate the percentage of intra-pupillary space the cataract 
opacity occupies: from grade 1 obscuring 10% of the intra-pupillary space to grade 4+ 
obscuring more than 90% of the intra-pupillary space.  There are three types of cataracts 
(Murrill et.al.,1995).  A cataract which occurs by natural processes (i.e., aging) is called a 
senile cataract.  In contrast, an acquired cataract is caused by an injury, whereas a 
congenital cataract is present at birth.  In this study, we will be focusing only on senile 
cataracts, and the term cataract will refer to a senile cataract. 
 The number of people afflicted by a senile cataract in either eye is growing at a 
rapid rate.  An estimated 20.5 million people over the age of 40 in America have a 
cataract in either eye and is estimated to rise to 30.1 million by 2020 (The Eye Diseases 
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Prevalence Research Group, 2004).  Cataract induced vision impairment and blindness 
can lead to a decrease in quality of life for elderly people, difficulties in daily activities, 
and loss of independence and self-esteem (Hall, McGwin & Owsley, 2005).  Cataract 
induced visual impairment can have a number of negative side effects, particularly in the 
independence of an older individual.  Cataracts can affect a person’s independence by 
affecting their driving abilities, which can be remarkably improved by bilateral cataract 
surgery (Wood & Carberry, 2006).  In addition to driving performance, a person’s 
confidence in driving can be affected by the visual effects of cataracts.  Elderly 
individuals with cataracts were approximately twice as likely to report a reduction in the 
number of days they have driven and the number of destinations per week, with an 
increase in preferring someone else to drive compared to their peers without cataracts 
(Owsley, Stalvey, & Wells, 1999).   
 Cataract surgery is performed when the cataract significantly interferes with a 
patient’s visual acuity and can no longer be corrected by prescription glasses.  Cataract 
removal is now one of the most commonly performed ambulatory surgical procedures 
with more than three million such surgeries performed each year (Cullen et al., 2009).  
This surgery consists of phacoemulsification, or a breaking up of the natural lens, which 
houses the cataract.  Then an intraocular artificial lens (IOL) is implanted.  This IOL is 
clear and has a certain amount of corrective power, which is calculated for each patient.  
This surgery can generally be done in an out-patient setting.  Over 85% of patients report 
an improvement in function and satisfaction with their vision after undergoing cataract 
surgery (Steinberg, et al., 1994).  There are other benefits of cataract surgery besides 
visual satisfaction.  For example, impairment of vision by cataracts can cause a 
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significant decrease in employment opportunities, and cataract surgery can contribute to 
poverty alleviation by increasing a person’s ability to work (Kuper et al, 2010). 
 
Depression in Elderly 
 The presence of medical problems (e.g., diabetes, pulmonary disease, heart 
disease, and arthritis) is associated with an increased comorbidity with depression 
(Katon, Lin, & Kroenke, 2007).  An Agency for Healthcare Research and Quality 
systematic review reported that up to 20% of coronary heart disease patients meet criteria 
for a major depressive disorder (MDD), and up to 47% have significant patient-reported 
depressive symptoms, these diagnoses/symptoms remain long after discharge (Bush et 
al., 2005).  Another large study of coronary heart disease patients found that depression 
was again an important correlate of diminished quality of life, while two traditional 
measures of cardiac function, ejection fraction and ischemia, were not (Ruo et al., 2003).   
 MDD is a condition with certain symptoms that last for at least 2 weeks.  In 
addition to persistent feelings of sadness and/or anhedonia, other symptoms of MDD 
include significant weight loss or gain, insomnia or hypersomnia, psychomotor agitation 
or retardation, fatigue or loss of energy, diminished concentration or indecisiveness, and 
recurrent thoughts of suicide or death (DSM-IV, 1994).  A mild form of depression has 
few, if any, of the listed symptoms and only has a minor impairment in occupational or 
social functioning.  A moderate form of depression has some of the symptoms listed and 
mild to moderate impairments to social and occupations.  In contrast, the severe form of 
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depression consists of several of the symptoms in excess and a marked interference with 
occupational and/or social functioning (DSM-IV, 1994).    
 More than 6.5 million of the 35 million Americans aged 65 or older are affected 
by symptoms of depression (Duckworth, 2009).  Depression can often go untreated in the 
elderly group, due to beliefs that depression in elderly is a normal part of aging in 
response to chronic illness, loss, and social transition.  Similar to decreases in visual 
acuity, late-life depression can cause a decrease in quality of life for an individual 
(Unützer et al., 2000).  Late-life depression can affect quality of life in numerous ways.  
This late-life depression can increase risk for other medical illnesses (Duckworth, 2009).  
For example, depression can affect health and healing following a stroke or myocardial 
infarction (Frasure-Smith, et.al., 1993).   Furthermore, late-life depression is associated 
with increased fatality by both suicide and non-suicide (Duckworth, 2009).  That is, 
individuals with depression have a higher death rate than those without depression, and 
late-life depression is associated with increased suicidal ideation, which in turn may lead 
to mortality by suicide (Henriksson et. al, 1995) 
Relation Between a Decreased Acuity of the Senses and Depression 
 Senses are crucial to one’s well-being and functionality.  As people age, their 
senses start to decrease in acuity, causing them to have more difficulties with vision and 
hearing.  This can make it difficult for them to enjoy activities they once may have 
enjoyed, like having a conversation, playing card games, or watching TV.  However, few 
studies have examined the relation between cataracts and depression specifically.  One 
study showed that there are higher levels of depressive symptoms and a higher 
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prevalence of MDD in low-vision elderly patients (Rovner & Shmuely-Dulitzki, 1997).  
This study utilized the Geriatric Depression Scale (GDS), a 30 item self-rated 
questionnaire to look at depression in elderly and a community disability scale to 
measure function in daily activities.  Participants were recruited from a low-vision clinic 
afflicted with various eye diseases (e.g. macular degeneration, glaucoma), but 
participants’ visual acuity was not examined for the study.  This study found that the 
depressive symptoms were common among visually impaired elderlies.   
 Another big study (Owsley et al., 2007) aimed to look at the effect of treating 
uncorrected refractive error on vision-targeted health-related quality of life and 
depression in nursing home residents.  Participants completed the VF-14, a visual 
functioning questionnaire aimed at measuring vision-related quality of life (VRQOL) and 
the GDS at baseline and at the 2-month follow-up.  In this study, an immediate correction 
group was given updated lenses after the baseline questionnaires, and a delayed 
correction group received updated corrective lenses after the 2 month follow up. The 
delayed correction group served as the control group. The immediate correction group 
exhibited increased vision-targeted health-related quality of life (QoL) and fewer 
depressive symptoms, when comparing baseline to follow-up data, and compared to the 
control group.  Thus, increasing the quality of vision through updated glasses, decreased 
the levels of depressive symptoms and increased VRQOL.  
 Just like vision, hearing is a fundamental sense, and reactions to such life-
changing losses in vision and hearing could be similar.  Therefore, reviewing the relation 
between depression and other similar senses, like hearing, in the elderly population can 
help us understand the relation between depression and vision.  A study on depression 
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comorbid with hearing loss demonstrated that there was a significant decrease in 
depressive symptoms with the use of hearing aids (Boi et al, 2012).  More specifically, at 
6 months after the use of the programmable hearing device, levels of depressive 
symptoms decreased significantly, while hearing ability and quality of life increased. 
Likewise, another study showed strong correlations among hearing impairment, 
depressive symptoms, and quality of life (Ishine, et al., 2007).  This study compared 
elderly with hearing impairments and elderly without hearing impairments in their 
depressive symptoms and quality of life using the GDS, Subjective Quality of Life 
(QOL), and Activities of Daily Living (ADL).  Those with hearing impairments had 
significantly lower QOL and ADL scores and higher depression scores than their peers 
without hearing impairments.  The researchers suggested that other sensory functions (i.e. 
vision) might also be related to depression, the ADL, and the QOL in the elderly 
population. 
  Few studies have been conducted in order to examine the relation between 
cataract related vision loss and depression, but the relation is expected to be similar to 
that of hearing and depression.  A recent study (McGwin, Li, McNeal & Owsley, 2003) 
on the relationship between cataracts and depression did not support the hypothesis.  In 
this study, three groups of elderly were recruited: one group of patients undergoing 
cataract surgery, a group of patients who choose to forego surgery, and individuals who 
had no cataract.  All three groups of participants completed the following questionnaires: 
a cognitive health questionnaire was used to assess the cognitive function of the elderly 
participants; the 20 item Center of Epidemiological Studies Depression Scale (CES-D) 
was used to assess depressive symptoms; and a general health questionnaire to assess 
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presence and absence of symptoms of 17 types of diseases (e.g. heart disease, cancer, 
diabetes).  In addition, a visual acuity test and contrast sensitivity test were administered 
at baseline and 6 and 12 month marks.  There were no significant differences between the 
baseline and follow up depression scores in patients who underwent cataract corrective 
surgery compared to the patients forewent the surgery.  
  A recent study (Ishii, Kabata, & Oshika, 2008) examined cognitive impairment, 
depression, and VRQOL in individuals who were about to undergo cataract surgery for 
bilateral cataracts.  Participants completed the visual functioning questionnaire (NEI 
VFQ-25) to measure VRQOL, the Mini-Mental State Examination (MMSE) to measure 
cognitive impairment, and the Beck Depression Inventory (BDI) to measure depressive 
symptoms, at a baseline, before surgery, and two months after the surgery.  The study 
found that VRQOL, cognitive impairment, and depressive mental status are strongly 
related with one another.  The improvement to the VRQOL via cataract surgery led to 
improved cognitive functioning and decreased depressive symptoms.  While depressive 
symptoms decreased at post-operation, the changes were not statistically significant.  
Only the improvement in VRQOL and cognitive impairment at post-operation were 
statistically significant.  In addition, there was a strong correlation between the change in 
the NEI VFQ-25 and the BDI, showing the relationship between VRQOL and depressive 
symptoms.  It is important to note that there was no control group, while the other study 
(McGwin et al., 2003) did utilize a control group.  
 Another study (Fagerström, 1994) examined the association between depression 
and vision.  One hundred participants were observed for the first eye cataract removal 
operation.  The participants completed questionnaires regarding socio-demographic 
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background, diagnosed diseases, a Snellen eye-chart for visual acuity, the BDI, and a 
personality test, the 71 item Mini-Mult Minnesota Multiphasic Personality Inventory 
(MMPI).  These questionnaires were presented orally one day before the operation and 3 
months after the operation.  The study found that visual acuity significantly improved and 
depressive symptoms significantly decreased.  Before cataract operation, nearly blind 
participants were more depressed than those who had binocular vision, but the 
association was not statistically significant.  However, depression and visual acuity were 
significantly correlated after the operation.  Depression following the cataract operation 
could be partly explained by the presence of other somatic diseases (e.g. cardiovascular 
disease, asthma, cerebrovascular disease).  It is important to note that this study also did 
not have a control group of participants who did not undergo the surgery. 
 The studies discussed above show different results.  One study (Ishii et al., 2008) 
indicated that there was a correlation between VRQOL and depression after cataract 
surgery. Similarly, Fagerström (1994) showed that there was a significant decrease in 
depressive symptoms and that is correlated with visual acuity post-surgery. In contrast, 
McGwin et al. (2003) demonstrated that there was no significant improvement in 
depression after cataract surgery compared to a control group.  These inconsistencies may 
be due to the fact that the studies used different measures to assess depressive symptoms: 
McGwin et al. (2003) used the CES-D, whereas Ishii et al., (2008) used the BDI and 
Fagerström (1994) utilized mainly the BDI, the Mini-Mult MMPI and the Snellen eye 
chart.  
 Because these studies that examined the relation between cataract-related vision 
loss and depression and quality of life yielded inconsistent findings, the effects of cataract 
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surgery on depressive symptoms and VRQOL still remains equivocal.  More studies in 
this area must be conducted in order to better understand the relation.  This is important 
because with the increase in age of America and the world will come the increase in 
cataracts and the need for surgery.    Awareness of the psychological aspects of cataract 
related vision loss is important for health care providers to understand, which may help 
patients make informed decision regarding cataracts that can be detrimental if left 
untreated.   
Hypotheses 
 The hypotheses of the current research are as follows. First, levels of depressive 
symptoms will decrease in those who undergo the cataract surgery, while those who do 
not undergo cataract surgery (i.e., a wait-list control group) will demonstrate no change in 
depressive symptoms. Second, visual acuity and vision-related quality of life will 
increase in those who undergo the cataract surgery compared with the wait-list control 
group. 
 
Method 
Participants 
 Two groups of participants were recruited from Family Eyecare in Dover-
Foxcroft, Maine.  The two groups are: (A) participants who had a cataract that is at 
removal stage but are not yet undergoing intraocular lens replacement (i.e., a wait-list 
control group) and (B) participants who have a cataract and have an upcoming intraocular 
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lens replacement (i.e., a surgery group).  All participants have a cataract at a stage of 1+ 
NS or higher without other significant ocular concerns (eg. Macular degeneration, severe 
glaucoma), which was determined by Dr. David P. Frasz.   
Recruitment 
 Individuals were eligible for the current study if they had a cataract at a stage of 
1+ NS or greater and had no previous cataract surgeries.  These eligible patients were 
approached by the investigator using the following script: “Hi Mr. /Ms. Blank, my name 
is Paige Martin.  I am one of Dr. Frasz’s assistants as well as a student at the University 
of Maine.  I am interested in researching cataract surgery and the quality of life.  I was 
wondering if this is something you would be interested in participating in.  This is 
completely voluntary and will have no effect on your care if you decide not to 
participate.”  If the patient agreed to participate, an informed consent form and a medical 
records release form were given to participants.  Each participant read and signed the 
forms.  By signing the medical records release form, patients gave the investigator 
permission to take the visual acuity, age, and gender information from their medical 
records. 
 
Questionnaires 
 Both groups of participants were given two questionnaires to complete at two 
different time points, approximately one month apart from each other.  These 
questionnaires were: the Center of Epidemiologic Studies Depression Scale (CES-D; 
Radloff, 1977), a widely used measure to assess depressive symptoms and the Visual 
12 
 
Functioning Quality of Life (VF-14 QOL; Weisinger, 2009), a measure assessing visual 
functioning and its effects on a person’s daily life.  The surgery group was given these 
questionnaires at the pre-operative appointment about 2 to 4 days prior to surgery, which 
served as a baseline.  The surgery group then underwent the intraocular lens replacement 
surgery performed by Dr. David P. Frasz at Mayo Regional Hospital.   Follow-up 
questionnaires, which again were the CES-D and the VF-14 QOL, were given at one 
month following the surgery. 
 The wait-list control group was given the same questionnaires (i.e., the CES-D 
and the VF-14 QOL) after one of their appointments.  Participants in the wait-list control 
group did not have a follow-up appointment within the month.  Therefore, follow-up 
questionnaires were mailed a month after they initially completed the measures, with a 
pre-stamped envelope to return the measures.  Participants were instructed to fill out the 
one month follow up questionnaires and return them in the provided envelope. 
Visual Acuity Measure  
Participants from both groups had an assessment of their visual acuity with the Snellen 
eye chart (Snellen, 1862).  The Snellen Eye Chart measures visual acuity based on letters 
set at certain ratios, and the 20/20 line is considered normal visual acuity.  Both groups 
were assessed for best corrected vision at their initial appointment.  Participants in the 
surgery group were assessed again at their one month post-operative appointment. 
Participants in the wait-list control group were not assessed at a follow-up point; it was 
assumed that their vision had not changed from their initial appointment.  
Results 
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Demographic Characteristics 
 The present study consisted of two groups of participants.  A cataract surgery 
group (n=26) and a wait-list control group (n=20). Two participants from the surgery 
group were excluded from the analysis, because they did not have follow-up information. 
Thus, data from 24 participants in the surgery group were included in the analyses.  At 
baseline, the two groups had similar distributions of demographic characteristics (Table 
1).  The surgery and the wait-list control groups did not differ in their sex composition 
(χ2(1)=.642, p=.432) and  age (t(42)=.009, p=.321).  
 
Visual Acuity 
 Table 2 presents visual acuity at baseline and at follow-up.  The visual acuity is in 
logMAR form, taking the Snellen eye chart assessment and putting it into a logarithmic 
scale so that analysis could be performed.  The formula for calculating Snellen into 
logMAR is: logMAR visual acuity= -log10(Snellen ratio).  Snellen ratio of 20/20 equals 
to logMAR of 0, and Snellen ratio of 20/200 equals to logMAR of 1.  Best corrected 
vision of the affected eye was taken at baseline and follow-up.  At baseline, the surgery 
group had overall a higher mean of logMAR visual acuity (mean = .669, SD=.303), 
Table 1. Baseline Demographic Characteristics 
Variable P Value
Sex, No (%)
Female 14 (58.3) 14 (70)
Male 10 (41.7) 6 (30)
Age, mean (SD) 69.4 (7.7) 69.37 (10.1) 0.321
Control Group 
(n=20)
Surgery 
Group (n=24)
0.432
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indicating a lower overall visual acuity than the control group (mean= .310, SD=.194), 
with a significant difference between the two groups at baseline (F(1,42)=16.397, 
p<.001).  The change in visual acuity from baseline to follow-up for the surgery group 
improved significantly (t(23)=8.00, p<.001).  It was assumed that the control group had 
no change in vision from baseline to follow-up. 
 
Vision-Related Quality of Life and Depression 
 Table 3 displays the baseline and follow-up VRQOL and levels of depressive 
symptoms for both the surgery and control groups.  First, group x time repeated measures 
ANOVA was conducted with the scores on the VF-14 as a dependent measure to assess 
changes in VRQOL. There was a significant main effect of time, F(1, 42)=18.75, p<.001, 
which was qualified by a significant group x time interaction, F(1,42)=7.405, p=.009, 
suggesting that the change in VRQOL from the baseline to follow-up points in the control 
group were significantly different from the change in the surgery group.  Follow-up 
within-group analyses revealed that VRQOL improved significantly from baseline to 
Best Corrected 
Vision, logMAR
.669 (.303) .156  (.230) <0.001
Table 2. Visual Acuity for surgery and control at baseline and follow-up
Baseline 
Mean (SD)
P Value
Follow-up 
Mean (SD)
Surgery Group (n=24)
Control Group (n=19)
Best Corrected 
Vision, logMAR
0.310 (.194) .310 (.194)
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follow-up in both the surgery group (t(23)= -4.078, p<.001) and the wait-list control 
group  (t(19)= -2.322, p=0.031).  Follow-up between group analyses demonstrated that 
the two groups significantly differed in their VRQOL at baseline (t(42)=2.727, p=.031), 
with the surgery group reporting significantly lower VRQOL.  A between group analysis 
demonstrated that at the follow-up point the two groups did not significantly differ in 
their VRQOL (t(42)=.251, p=.227). 
 Next, group x time repeated measures ANOVA was conducted with the scores 
from the CES-D to examine changes in symptoms of depression.  Although none of the 
effects were significant (all ps<.09), t-tests were conducted to further examine the 
pattern.  The CES-D scores for surgery group significantly decreased (t(23)=2.099, 
p=0.047), while the control group’s CES-D scores did not significantly change from 
baseline to follow-up (t(19)=.444, p=.662).  Both at baseline (t(42)=-1.083, p=.723) and 
at follow-up (t(42)=-.474, p= .546), the control and surgery groups did not significantly 
differ in their levels of depressive symptoms.    
 
  
Discussion 
Baseline Follow-up Baseline Follow-up
VF-14, mean (SD) 70.5 (19.64) 87.21 (14.20) 84.37 (12.51) 88.18(10.97)
CES-D, mean (SD) 10.88 (7.71) 8.79 (8.43) 8.20 (8.65) 7.7  (6.46)
Cataract surgery group (n=24) Control wait-list group (n=20)
Table 3 Outcome: Vision-related quality of life and depression
Variable
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 This study aimed to examine the impact of cataract surgery on depressive 
symptoms and VRQOL in cataract patients undergoing surgery (i.e., the surgery group) 
and cataract patients not yet undergoing surgery (i.e., wait-list control group).  It was 
hypothesized that individuals in the surgery group will exhibit a greater decrease in 
depressive symptoms and greater increases in VRQOL and visual acuity than individuals 
in the wait-list control group.  Inconsistent with the hypotheses, cataract corrective 
surgery did not significantly reduce depressive symptoms in elderly patients compared to 
patients who have not received the surgery. However, VRQOL significantly improved 
following cataract corrective surgery. 
 Few studies have examined cataract surgery’s effect on depression and VRQOL 
in regards to a control and surgery groups. Furthermore, results from the previous studies 
are inconsistent.  One study (McGwin, Li, McNeal & Owsley, 2003) found that 
depressive symptoms did not change significantly difference from the baseline to follow-
up in those who underwent surgery and those who did not. In contrast, another study 
(Ishii, Kabata, & Oshika, 2008) examined depression and VRQOL and found that 
VRQOL had improved significantly post operation and that depressive symptoms had a 
near statistically significant decrease post-operatively. However, it is important to point 
out that Ishii et al. (2008) did not have a control group to compare the findings to. Earlier, 
Fagerström (1994) found that visual acuity significantly increased and depression 
significantly decreased following the surgery. It was also found that the visual acuity and 
depression were significantly correlated: The better the outcome of the visual acuity after 
surgery, the better the relief of depressive symptoms. It is important to note that this 
study had no control group. The current findings are consistent with some of these 
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previous studies demonstrating an increase in both visual acuity and VRQOL and no 
significant change in depressive symptoms following the surgery.   
 As expected (Fagerström, 1994 & McGwin et al., 2003), visual acuity did indeed 
increase significantly with cataract corrective surgery in the current study.  Vision is one 
of the most depended upon senses, on which many everyday activities like cooking, 
driving, reading, and watching TV rely.  By decreasing vision and decreasing the ability 
to which glasses can correct the vision, cataracts lead to difficulty performing many of 
these enjoyable and/or necessary activities.  As a result, many people become dependent 
upon someone else to help them read medicine bottles, cook, and enjoy TV.  Due to 
decrease in their independence, elderly people may be more likely to become depressed. 
If an elderly person could regain their independence, depressive symptoms might be 
eliminated.  Indeed, updating uncorrected refractive error in nursing home residents 
significantly improved quality of life and decreased symptoms of depression (Owsley et 
al., 2007).  The residents who received updated prescription glasses experienced less 
psychological distress, including less depressive symptoms and increase in social 
interaction.  Like an updated prescription, cataract surgery also increases visual acuity; 
therefore the same benefits can be expected due to the increase of visual acuity.  
 In the current study, VRQOL significantly improved from baseline to follow-up 
in the surgery group, and the degree of change in VRQOL in the surgery group was 
significantly different from the control group.  These findings are consistent with other 
studies examining cataract surgery and other vision debilitating problems (Ishii et al., 
2008; Boisjoly et al., 1999).  Scores on the VF-14 correlated with an overall health 
related quality of life, suggesting that improvements in one aspect of health quality of life 
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may increase the overall health quality of life (Desai et al., 1996). Therefore, Gains in 
VRQOL due to improved visual acuity from cataract corrective surgery will likely be 
translated into gains in overall health related quality of life.   
Previous research demonstrated correlations between depression and many physical and 
psychological diseases, like heart disease or dementia (Nöel et al., 2004).  For example, 
depression was an important correlate of diminished quality of life among patients with 
coronary heart disease, while two traditional measures of cardiac function, ejection 
fraction and ischemia, were not (Ruo et al., 2003).   It has also been shown that late-life 
depression increases physical disability and reduces the patient’s ability to care for 
themselves (Unützer et al., 2000).  Therefore, reducing the depressive symptoms and 
increasing VRQOL in an elderly person can have numerous implications, leading to an 
overall healthier life, more independence, and longevity of life.  
 In the current study, decreases in depressive symptoms in the surgery group were 
not significantly different from the wait-list control group.  It is possible that cataract 
surgery does not necessarily affect levels of depressive symptoms.  However, the lack of 
group differences in depressive symptoms might be due to floor effects. That is, most 
participants in this study exhibited minimal depressive symptoms. A score of 16 or 
greater on the CES-D identifies participants who are at risk for clinical depression, and 
the average scores for both groups at baseline were less than 16 to begin with.  Very few 
participants at baseline exhibited CES-D scores of 16 or above (n=9).    Future studies 
could examine the effects of cataract surgery on depression among elderly patients who 
exhibit more depressive symptoms than the participants in the present study.   
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 The environment in which participants in the control group were questioned could 
have also masked any group differences.  At baseline, both the surgery and the wait-list 
control groups were presented with the questionnaires at the physician’s office, along 
with the other preliminary paperwork for the study.  The surgery group completed 
follow-up paperwork at a one month post-operative appointment in the office.  The 
control group, however, completed the follow-up measures at home and returned in a 
provided pre-stamped envelope.  It may be that participants were more stressed and 
thinking on their health issues while at the physician’s office.  It is well known that many 
people react negatively to doctor’s visits known as the “white coat effect” (Spruill, et al., 
2007).  The “white coat effect” is an anxiety which is associated with the presence of a 
health care provider, particularly seen in blood pressure level which is higher than a 
pressure taken at home (Verdecchia, et al., 2002).  One study found that the “white coat 
effect” may not only be limited to the time that a patient sees the physician, but also 
extend to the whole clinical experience (Gerin et al., 2006).  That is, presenting higher 
blood pressures in the office, than found out of the office, even if the physician was not 
present during the measurement.  The same phenomena may be at play for the 
participants in the present study.  Completing the VF-14 and the CES-D at home at 
follow-up might have led the participants in the control group feel more comfortable, 
which might have inadvertently affected their responses.  Therefore, different settings for 
follow-up tests could have reduced any group differences in changes in their depressive 
symptoms.  
 There are other limitations in the present study.  First, the timing of the follow-up 
may have not been ideal to detect changes in depressive symptoms.  It is possible that one 
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month was too short of a period to reveal any changes in depressive symptoms.  At the 
one month point most participants have had time to adjust to their new vision, have been 
prescribed updated glasses if needed, and have stopped all needed prescription eye drops.  
However, the participants may still be concerned about their vision and the post-operative 
attention that they need.   Future studies could include more than one post-baseline mark 
such as at 1, 3, and 6 months and 1 year.  Having multiple follow-up tests over a longer 
period of time will allow researchers to investigate the progression.  In turn, it will allow 
a better understanding of the long term benefits of cataract surgery and increased visual 
acuity.   
 Second, participants were not randomly placed into the control or surgery groups.  
Random assignment could ensure that any differences between the groups are not 
because of any pre-existing group differences in other variables.  In the current study, the 
wait-list control group was significantly different from the surgery group in baseline 
visual acuity.  The wait-list participants may not have a sense of urgency for the surgery 
(being asked to move up in the waitlist), because their vision is still at a level which they 
consider functional. 
 Lastly, participants in the current study were fairly homogenous.  Having 
conducted the present study in central Maine, all participants were Caucasian, most of 
who grew up in the area with similar values and similar levels of educations.  In a 
heterogeneous sample, for example, some people may be very open about depression, 
while other people may be very private and their responses might be affected by their 
desire to not show weakness or need for help.  Although homogeneity of the sample 
limits generalizability of the current findings, it can be assumed that the two groups (i.e., 
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surgery and the wait-list control groups) are similar in other variables that we did not 
measure.  Therefore, our finding that the surgery significantly improved VRQOL is less 
likely to be due to other third variables.  
 The population that is affected by cataracts is growing rapidly with an estimated 
30.1 million people over 40 with a cataract in either eye by the year 2020 (The Eye 
Diseases Prevalence Research Group, 2004).  Understanding not only the visual benefits, 
but also the mental and long term benefits will help both physicians and patients to make 
informed decisions regarding cataract surgery.  The current study demonstrated that 
cataract surgery not only increases visual acuity as it is aimed to do so, but also VRQOL, 
which in turn should increase the overall quality of life of a patient.  However, the current 
findings show that cataract surgery does not pose significant benefit regarding decreasing 
depressive symptoms particularly in patients with minimal depressive symptoms.  
Therefore, it may not be advantageous yet to consider lowering of depressive symptoms 
as a benefit of cataract surgery.  Further research could expand on all of the risks and 
benefits both psychologically and physically of an increasingly performed surgery.  
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Appendix: A 
Vision and Quality of Life Study  
Informed Consent Form 
 
 You are invited to participate in a research project being conducted by Paige 
Martin, an undergraduate student in the Department of Psychology at the University of 
Maine (Faculty Advisor: Lira Yoon). The purpose of the research is to investigate mood 
and quality of life in patients who choose to have or not to have cataract surgery.  
What Will You Be Asked to Do? 
 If you decide to participate, you will be asked to complete two questionnaires, 
now and at a one month follow up appointment. The questionnaires will take less than 30 
minutes to complete.  In addition to these questionnaires, information on your visual 
acuity, age, and gender will be obtained from your medical records for the purpose of this 
research. If you do not have a return appointment within about a month from now, the 
follow up questionnaires can be sent to you and filled out at home and returned to me 
with a self-addressed and stamped envelope that I will provide you.  
Risks 
 There is a possibility that you may be uncomfortable answering some of the 
questions (e.g., “I thought my life had been a failure”, “Because of my vision I had a hard 
time driving at night”). You have the right to skip questions you don’t wish to answer. If 
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your responses on these questionnaires seem to be concerning, it will be reported to Dr. 
Yoon, a Psychologist and the faculty sponsor of this project, and appropriate follow-up 
actions will be taken.  
Benefits 
 While there are no direct benefits to you from participating, we hope this study 
will help us to better understand the relation between vision and quality of life in older 
adults.  
Confidentiality 
 Data will be kept confidential. Except the consent form, which will be kept 
separate from the data, your name will not be on any forms. A code number will protect 
your identity.  All study files will be labeled with this ID number in place of a name and 
will be maintained in a locked office.  Electronic files will be kept with password 
protection.  Your name and other identifying information will not be reported in any 
publications. The key linking your name to the data will be destroyed after data analysis 
is complete (approximately in one year), but the investigator will keep the data, which 
only contains an ID number instead of your name, indefinitely.  The key and data files 
will be stored on separate computers.  
Voluntary 
 Participation is completely voluntary.  You are free to refuse to participate in the 
study or withdraw consent at any time during the study without giving reason.  You may 
skip any questions you do not want to answer. Refusal in participating in this study or 
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withdrawal during the study, will in no way affect the quality of your treatment or 
relationship with Dr. Frasz or this office.  
 
Contact Information 
 If you have any questions about this research, please contact Paige Martin (email: 
paige.miles@maine.edu). You may also reach the faculty advisor on this study, Dr. Lira 
Yoon at lira.k.yoon@umit.maine.edu. If you have any questions about your rights as a 
research participant, please contact Gayle Jones, Assistant of the University of Maine’s 
Protection of Human Subjects Review Board at 581-1498 or email: 
gayle.jones@umit.maine.edu.  
Your signature below indicates that you have read and understand the above 
information. You will receive a copy of this form.  
 
_______________________________                             _____________ 
Signature of Participant        Date  
 
Address for follow-up paperwork to be sent to: 
Street:___________________________________________ 
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City:_____________________________   State___________________   
Zip___________ 
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Appendix: B 
ID: ________________ DATE: _______________ 
 
CES-D 
Instructions:  Below is a list of ways people sometimes feel or behave.  For each item, 
please think and indicate how often or how consistently you have felt or behaved this 
way during THE PAST TWO WEEKS by circling the appropriate response number. 
__________________________________________________________ 
During the past two weeks: 
 0 = RARELY (less than 3 days over the past two weeks) 
 1 = SOMETIMES (a total of 3 days spread out over the past two       weeks) 
 2 = OFTEN (a total of 4-7 days over the past two weeks) 
 3 = MOST OF THE TIME (more than 7 days) 
__________________________________________________________ 
1.  I was bothered by things that usually don’t bother me         0    1    2    3 
2.  I did not feel like eating; my appetite was poor.           0    1    2    3 
3.  I felt that I could not shake off the blues even with help from my  
family or friends.            0    1    2    3   
 4.  I felt that I was just as good as other people.         0    1    2    3 
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 5.  I had trouble keeping focused.          0    1    2    3 
 6.  I felt depressed.             0    1    2    3  
 7.  I felt that everything I did was an effort.          0    1    2    3 
 8.  I felt hopeful about the future.           0    1    2    3 
 9.  I thought my life had been a failure.          0    1    2    3 
10. I felt fearful.            0    1    2    3 
11. My sleep was restless.            0    1    2    3 
12.  I was happy.             0    1    2    3 
13.  I talked less than usual.            0    1    2    3 
14.  I felt lonely.             0    1    2    3 
15.  People were unfriendly.            0    1    2    3 
16.  I enjoyed life.                         0    1    2    3 
17.  I had crying spells.           0    1    2    3 
18.  I felt sad.              0    1    2    3 
19.  I felt that people dislike me.           0    1    2    3 
20.  I could not get “going”.            0    1    2    3  
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Appendix: C 
VF- 14 QOL Questionnaire 
Because of your vision, how much difficulty do you have with the following activities? 
Check off the box which best describes how much difficulty you have, even with glasses. 
Activity None A Little Moderate A Great 
Deal 
Unable To 
Do 
1. Reading small print, 
such as medicine bottle 
labels, a telephone 
book or food labels 
     
2. Reading a newspaper or 
a book 
     
3. Reading a large-print 
book or large print 
newspapers or numbers 
on telephone 
     
4. Recognizing people 
when they are close to 
you 
     
5. Seeing steps, stairs or 
curbs 
     
6. Reading traffic signs, 
street signs or store 
signs 
     
7. Writing checks or 
filling out forms 
     
8. Playing games such as 
bingo, dominos, or card 
games 
     
9. Taking part in sports like 
bowling, handball, tennis, 
golf 
     
10.  Cooking      
11. Watching    television      
12. Doing fine handwork 
like sewing, knitting 
crocheting, carpentry 
     
13. Driving during the day      
14. Driving at night      
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Appendix: D 
Family Eyecare 
David P. Frasz, M.D. 
AUTHORIZATION for the Use and/or Disclosure 
of HEALTH INFORMATION 
 
  
Name:                                                                 Address:  _________________                                                                                               
 
Telephone:                                                DOB:   ________________                             
 
Instructions: Please complete all of the sections of this form. Please note incomplete 
or inaccurately completed forms will not be honored. 
 
I hereby authorize Family Eyecare to use and/or disclosure of my health information as 
described below: 
 Visual Acuity, Age and Gender from (pre-op date) to (1 month post-op date) 
I understand that my specific consent is required to use and/or disclose information 
pertaining to treatment and/or diagnosis of mental health conditions, substance abuse 
and/or HIV status.  Please fill out all of the sections even if one or more of them are not 
applicable to you.  Any of the following sections not completed will be presumed to be a 
refusal to authorize use and/or disclosure of such information. (The information below 
will not be FAXED even if disclosure is authorized.) 
 
(A) HIV status information.  I DO/DO NOT (Circle one) authorize use and/or disclosure 
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of health information related to testing, diagnosis or treatment of HIV, ARC or AIDS.  
 
(B) Substance Abuse Treatment Information.  I DO/DO NOT (Circle one) authorize use 
and/or disclosure of health information related to treatment, testing or diagnosis of 
alcohol or substance abuse. Substance abuse treatment information may not be 
re-disclosed without the Individual’s express written authorization or as otherwise 
permitted by law.  Unless otherwise revoked, this SPECIFIC authorization will expire on 
________, 20___ or 6 months from the date of signing whichever comes first. 
 
(C) Mental Health Treatment Information.  I DO/DO NOT (Circle one) authorize use 
and/or disclosure of health information related to mental health treatment, not including 
Psychotherapy Notes which cannot be disclosed pursuant to this Authorization. 
 
(D) Sexually Transmitted Disease Information.  I DO/DO NOT (Circle one) authorize 
use and/or disclosure of health information related to Sexually Transmitted Diseases. 
 
The Purpose of Use and/or Disclosure is:  for a research study entitled, “Effect of 
Cataract Surgery on Depression in Older Adults”                                                           
Release Information to: (Name of Individual or Facility):  Paige Martin                                                                 
Address:  University of Maine, Psychology Department, 301 Little Hall, Orono, ME  
04469    
 
Subsequent Disclosures: I DO /DO NOT (Circle one) authorize subsequent disclosures to 
be made of the health information identified above.  This does not apply to re-disclosure 
of alcohol or substance abuse treatment information disclosed under section (B) above. 
 
   * I understand I have the right to revoke this authorization at any time by sending a 
written revocation  to Paige Martin. I understand the revocation will not apply to 
information that has already been released in response to this authorization and may be 
the basis for the denial of health benefits or other insurance coverage or benefits.  
   * Unless otherwise revoked, this authorization will expire on ___________, 20__, or 30 
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months from the date of signing whichever comes first. 
   * I understand that authorizing the use or disclosure of this health information is 
voluntary.  
   * Partial or incomplete disclosures, as compared to the information requested to be 
disclosed, will be labeled as such. 
   * I can refuse to sign this authorization.  I need not sign this form in order to assure 
treatment, payment, enrollment in a health plan or eligibility for benefits (if applicable), 
except (a) if my treatment is related to research, then an authorization may be required; or 
(b) if the purpose of the health care is solely to create health information to be provided 
to a third party, then an authorization may be required. 
   * I may refuse to disclose all or some health information, but that refusal may result in 
improper diagnosis or treatment, denial of coverage or claim for health benefits or other 
insurance or other adverse consequences.  
   * I understand that I have a right to a copy of this authorization.  
   * I understand any disclosure of information carries with it the potential for 
unauthorized re-disclosure and the information may not be protected by federal or state 
confidentiality rules anymore.  
   * If I have questions about use or disclosure of my health information, I may contact 
Paige Martin, 207/902-2780 
 
 
Signature: _______________________________________________ Date: 
_______________________ 
 
Parent/Guardian:                                                                                     
 Date:________________________ 
 (if under 18 years of age) 
 
Personal Representative:                                                                          
 Date:________________________ 
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IF NOT SIGNED BY THE INDIVIDUAL, PLEASE PROVIDE THE 
FOLLOWING INFORMATION: 
 
Relationship to the 
Individual:_____________________________________________________ 
 
Describe Authority to Act for Individual: 
_______________________________________ _____ 
 
 
 
RE-DISCLOSURE OF MEDICAL RECORD INFORMATION IS STRICTLY 
FORBIDDEN BY RECIPIENTS UNLESS DULY AUTHORIZED BY THE 
PATIENT. 
 
 
 
ADDITIONAL NOTICE TO RECIPIENTS OF SUBSTANCE ABUSE 
TREATMENT INFORMATION: This information has been disclosed to you from 
records protected by federal confidentiality rules (42 CFR Part 2). The federal rules 
prohibit you from making any further disclosure of this information unless further 
disclosure is expressly permitted by the written consent of the person to whom it pertains 
or as otherwise permitted by 42 CFR Part 2. A general authorization for the release of 
medical or other information is NOT sufficient for this purpose. The federal rules restrict 
any use of the information to criminally investigate or prosecute any alcohol or drug 
abuse patient. 
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Author’s Biography 
 Paige Martin was born in Bangor, Maine on April 2
nd
, 1992.  She graduated with 
High Honors from Foxcroft Academy in Dover-Foxcroft, ME, and enrolled in the Honors 
College at the University of Maine in 2010.  Pursuing degrees for both psychology and 
biology, Paige also has a minor in neuroscience and has completed the pre-medical 
course requirements.  Paige has been active in research while at the university receiving a 
College of Language Arts Fellowship, Carolyn E. Reed Pre-Medical Honor’s Thesis 
Fellowship, and the Maine INBRE Summer Fellowship. 
 Next school year Paige plans to finish her fourth year, continuing her work on her 
psychology and biology degrees at the University of Maine.  Upon graduation, Paige 
plans to apply to medical schools and pursue a career in the medical field focusing on 
neurology.  
 
 
 
 
 
 
